• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白90抑制对树突状细胞的表型和功能影响

Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cell.

作者信息

Bae Jooeun, Mitsiades Constantine, Tai Yu-Tzu, Bertheau Robert, Shammas Masood, Batchu Ramesh Babu, Li Cheng, Catley Lawrence, Prabhala Rao, Anderson Kenneth C, Munshi Nikhil C

机构信息

Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

出版信息

J Immunol. 2007 Jun 15;178(12):7730-7. doi: 10.4049/jimmunol.178.12.7730.

DOI:10.4049/jimmunol.178.12.7730
PMID:17548610
Abstract

The 90-kDa heat shock protein (Hsp90) plays an important role in conformational regulation of cellular proteins and thereby cellular signaling and function. As Hsp90 is considered a key component of immune function and its inhibition has become an important target for cancer therapy, we here evaluated the role of Hsp90 in human dendritic cell (DC) phenotype and function. Hsp90 inhibition significantly decreased cell surface expression of costimulatory (CD40, CD80, CD86), maturation (CD83), and MHC (HLA-A, B, C and HLA-DP, DQ, DR) markers in immature DC and mature DC and was associated with down-regulation of both RNA and intracellular protein expression. Importantly, Hsp90 inhibition significantly inhibited DC function. It decreased Ag uptake, processing, and presentation by immature DC, leading to reduced T cell proliferation in response to tetanus toxoid as a recall Ag. It also decreased the ability of mature DC to present Ag to T cells and secrete IL-12 as well as induce IFN-gamma secretion by allogeneic T cells. These data therefore demonstrate that Hsp90-mediated protein folding is required for DC function and, conversely, Hsp90 inhibition disrupts the DC function of significant relevance in the setting of clinical trials evaluating novel Hsp90 inhibitor therapy in cancer.

摘要

90千道尔顿热休克蛋白(Hsp90)在细胞蛋白的构象调节中发挥重要作用,进而影响细胞信号传导和功能。由于Hsp90被认为是免疫功能的关键组成部分,其抑制作用已成为癌症治疗的重要靶点,我们在此评估了Hsp90在人树突状细胞(DC)表型和功能中的作用。Hsp90抑制显著降低了未成熟DC和成熟DC上共刺激分子(CD40、CD80、CD86)、成熟标志物(CD83)以及主要组织相容性复合体(MHC,包括HLA-A、B、C和HLA-DP、DQ、DR)标志物的细胞表面表达,并且与RNA和细胞内蛋白表达的下调相关。重要的是,Hsp90抑制显著抑制了DC功能。它降低了未成熟DC的抗原摄取、加工和呈递,导致作为回忆抗原的破伤风类毒素刺激下T细胞增殖减少。它还降低了成熟DC向T细胞呈递抗原、分泌白细胞介素-12以及诱导同种异体T细胞分泌干扰素-γ的能力。因此,这些数据表明Hsp90介导的蛋白折叠是DC功能所必需的,相反,在评估新型Hsp90抑制剂治疗癌症的临床试验背景下,Hsp90抑制会破坏具有重要相关性的DC功能。

相似文献

1
Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cell.热休克蛋白90抑制对树突状细胞的表型和功能影响
J Immunol. 2007 Jun 15;178(12):7730-7. doi: 10.4049/jimmunol.178.12.7730.
2
Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells.热休克蛋白 90 对于调控人类 T 淋巴细胞和自然杀伤细胞的表型和功能活性至关重要。
J Immunol. 2013 Feb 1;190(3):1360-71. doi: 10.4049/jimmunol.1200593. Epub 2013 Jan 4.
3
Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.源自人骨髓的未成熟和成熟富集抗原呈递(树突状)细胞的抗原呈递及免疫调节能力
Hum Immunol. 2004 Feb;65(2):93-103. doi: 10.1016/j.humimm.2003.11.002.
4
Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB.格尔德霉素介导的热休克蛋白90抑制作用可部分激活树突状细胞,但会干扰其完全成熟,并伴有RelB上调受损。
J Exp Clin Cancer Res. 2014 Feb 13;33(1):16. doi: 10.1186/1756-9966-33-16.
5
Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions.在高温条件下,用Toll样受体(TLR)激动剂致敏的单核细胞衍生树突状细胞以CD40依赖的方式分泌白细胞介素-12p70。
J Immunother. 2006 Nov-Dec;29(6):606-15. doi: 10.1097/01.cji.0000211308.82997.4e.
6
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.1,25-二羟基维生素D3抑制树突状细胞的分化、成熟、活化及存活,导致同种异体反应性T细胞活化受损。
J Immunol. 2000 Mar 1;164(5):2405-11. doi: 10.4049/jimmunol.164.5.2405.
7
Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.通过BET溴结构域抑制剂JQ1抑制信号转导和转录激活因子5(STAT5)会破坏人树突状细胞的成熟。
J Immunol. 2015 Apr 1;194(7):3180-90. doi: 10.4049/jimmunol.1401635. Epub 2015 Feb 27.
8
IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.干扰素-α增强CD40配体介导的未成熟单核细胞来源树突状细胞的活化。
Int Immunol. 2002 Apr;14(4):367-80. doi: 10.1093/intimm/14.4.367.
9
Gliadin fragments induce phenotypic and functional maturation of human dendritic cells.麦醇溶蛋白片段可诱导人树突状细胞的表型和功能成熟。
J Immunol. 2005 Nov 15;175(10):7038-45. doi: 10.4049/jimmunol.175.10.7038.
10
Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.白细胞介素-10对人树突状细胞抗原捕获和抗原呈递的分裂活性:成熟步骤的定义
Eur J Immunol. 1997 Jan;27(1):26-34. doi: 10.1002/eji.1830270105.

引用本文的文献

1
XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial.在一项Ib/II期临床试验中,XL888和帕博利珠单抗调节了结直肠癌肿瘤的免疫格局。
Oncoimmunology. 2025 Dec;14(1):2475620. doi: 10.1080/2162402X.2025.2475620. Epub 2025 Mar 13.
2
Potential role of immunotherapy and targeted therapy in the treatment of cancer: A contemporary nursing practice.免疫疗法和靶向疗法在癌症治疗中的潜在作用:当代护理实践
Heliyon. 2024 Jan 17;10(2):e24559. doi: 10.1016/j.heliyon.2024.e24559. eCollection 2024 Jan 30.
3
Heat shock protein 90 is a new potential target of anti-rejection therapy in allotransplantation.
热休克蛋白 90 是同种异体移植中抗排斥治疗的一个新的潜在靶点。
Cell Stress Chaperones. 2022 Jul;27(4):337-351. doi: 10.1007/s12192-022-01272-2. Epub 2022 Apr 9.
4
Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy.诊断时HSP90α的血浆水平:接受PD-1/PD-L1抑制剂联合化疗的晚期肺癌患者临床结局的新型预后指标
Front Oncol. 2021 Dec 3;11:765115. doi: 10.3389/fonc.2021.765115. eCollection 2021.
5
DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications.基于 DNA 甲基化的肺腺癌亚型可以预测预后、复发和免疫治疗意义。
Aging (Albany NY). 2020 Nov 21;12(24):25275-25293. doi: 10.18632/aging.104129.
6
Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation.重新平衡蛋白质稳态可增强肿瘤抗原呈递。
Clin Cancer Res. 2019 Nov 1;25(21):6392-6405. doi: 10.1158/1078-0432.CCR-19-0596. Epub 2019 Jun 18.
7
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.热休克蛋白90(Hsp90)抑制作用会使同种异体反应性T细胞中的Ezh2蛋白不稳定,并减轻小鼠的移植物抗宿主病。
Blood. 2017 May 18;129(20):2737-2748. doi: 10.1182/blood-2016-08-735886. Epub 2017 Feb 28.
8
Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90.腹腔内热化疗通过暴露细胞表面热休克蛋白 90 引发抗肿瘤免疫反应。
Oncogene. 2016 Jan 14;35(2):261-8. doi: 10.1038/onc.2015.82. Epub 2015 Apr 13.
9
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells.热休克蛋白90抑制剂可增强黑色素瘤上的抗原表达,并增加T细胞对肿瘤细胞的识别。
PLoS One. 2014 Dec 12;9(12):e114506. doi: 10.1371/journal.pone.0114506. eCollection 2014.
10
Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB.格尔德霉素介导的热休克蛋白90抑制作用可部分激活树突状细胞,但会干扰其完全成熟,并伴有RelB上调受损。
J Exp Clin Cancer Res. 2014 Feb 13;33(1):16. doi: 10.1186/1756-9966-33-16.